Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Announcement Summary
For personal use only
Entity name
PARADIGM BIOPHARMACEUTICALS LIMITED..
Date of this announcement
Tuesday February 01, 2022
The +securities the subject of this notification are:
+Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends
Total number of +securities to be issued/transferred
Total number of | |||
ASX +security | +securities to be | ||
code | Security description | issued/transferred | Issue date |
New class - code | 125,000 Ordinary Shares issued at $1.89 per | 125,000 | 25/01/2022 |
to be confirmed | share, restricted and in escrow until 25 Jan 2023 | ||
New class - code | 125,000 Ordinary Shares issued at $1.89 per | 125,000 | 25/01/2022 |
to be confirmed | share, restricted and in escrow until 25 Jan 2024 | ||
New class - code | 125,000 Ordinary Shares issued at $1.89 per | 125,000 | 25/01/2022 |
to be confirmed | share, restricted and in escrow until 25 Jan 2025 |
Refer to next page for full details of the announcement
Notification of Issue, Conversion or Payment up of Unquoted | 1 / 10 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 1 - Entity and announcement details
For personal use only
1.1 Name of entity
PARADIGM BIOPHARMACEUTICALS LIMITED..
We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.
1.2 | Registered number type | Registration number |
ABN | 94169346963 | |
1.3 | ASX issuer code | |
PAR |
- The announcement is New announcement
- Date of this announcement
1/2/2022
Notification of Issue, Conversion or Payment up of Unquoted | 2 / 10 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 2 - Issue details
For personal use only
2.1 The +securities the subject of this notification are:
+Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends
2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:
does not have an existing ASX security code ("new class")
Notification of Issue, Conversion or Payment up of Unquoted | 3 / 10 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX
in an Appendix 3B
only | New +securities issued under an +employee incentive scheme | ||||||||
ASX +security code | +Security description | ||||||||
New class - code to be confirmed | 125,000 Ordinary Shares issued at $1.89 per share, | ||||||||
restricted and in escrow until 25 Jan 2023 | |||||||||
+Security type | ISIN code | ||||||||
use | Ordinary fully or partly paid shares/units | ||||||||
Date the +securities the subject of this notification were issued | |||||||||
25/1/2022 | |||||||||
Will all the +securities issued in this class rank equally in all respects from their issue date? | |||||||||
personal | Yes | ||||||||
Were any of the +securities issued to +key management personnel (KMP) or an +associate? | |||||||||
Yes | |||||||||
Provide details of the KMP or +associates being issued +securities. | |||||||||
Name of KMP | Name of registered holder | Number of +securities | |||||||
125,000 | |||||||||
Donna Skerrett | Donna Skerrett | ||||||||
Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under | |||||||||
listing rule 6.1? | |||||||||
Yes | |||||||||
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being | |||||||||
issued. | |||||||||
O dinary fully or partly paid shares/units Details | |||||||||
For | +Security currency | ||||||||
AUD - Australian Dollar | |||||||||
Are there CDIs issued over the +securities? | |||||||||
No | |||||||||
Is it a Partly Paid class of +security? | |||||||||
No | |||||||||
Notification of Issue, Conversion or Payment up of Unquoted | 4 / 10 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Is it a stapled class of +security?
No
Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms
https://www.asx.com.au/asxpdf/20201125/pdf/44q865364w4lhs.pdf
only | Any other information the entity wishes to provide about the +securities the subject of this notification | |||||||
Issue details | ||||||||
use | Number of +securities | |||||||
125,000 | ||||||||
personal | New +securities issued under an +employee incentive scheme | |||||||
ASX +security code | +Security description | |||||||
New class - code to be confirmed | 125,000 Ordinary Shares issued at $1.89 per share, | |||||||
restricted and in escrow until 25 Jan 2024 | ||||||||
+Security type | ISIN code | |||||||
Ordinary fully or partly paid shares/units | ||||||||
Date the +securities the subject of this notification were issued | ||||||||
25/1/2022 | ||||||||
Will all the +securities issued in this class rank equally in all respects from their issue date? | ||||||||
For | Yes | |||||||
Were any of the +securities issued to +key management personnel (KMP) or an +associate? | ||||||||
Yes | ||||||||
Provide details of the KMP or +associates being issued +securities. | ||||||||
Name of KMP | Name of registered holder | Number of +securities | ||||||
125,000 | ||||||||
Donna Skerrett | Donna Skerrett | |||||||
Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1?
Yes
Notification of Issue, Conversion or Payment up of Unquoted | 5 / 10 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Paradigm Biopharmaceuticals Ltd. published this content on 01 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 February 2022 05:21:07 UTC.